Ovarian cancer may be treated even if the patient responds favorably to chemotherapeutic drugs, owing to the fact that ovarian cancer may recur at times. Niraparib 100 mg Capsule is an anti-cancer medication that is indicated in certain regimes as part of maintenance therapy for patients who respond favorably to platinum-containing chemotherapy. It is a type of PARP inhibitor drug and is indicated in certain patients suffering from ovarian, fallopian tube or primary peritoneal cancer.
How Does Niraparib Target Cancer Cell Survival?
The mechanism of action of the capsule involves blocking poly (ADP-ribose) polymerases (PARPs) which assist the cells in DNA repair. By blocking these enzymes, DNA repair in some cancerous cells is hindered and they are unable to live. However, it is a unique mechanism by which the medicine differs from other medications used to treat cancer.
Can The Medicine Help Maintain the Response to Chemotherapy?
Another function of the therapy is the treatment of maintenance therapy after a complete or partial response to platinum chemotherapy where appropriate. Through its DNA repair interference mechanism, it may assist in prolonging time before disease progression occurs among suitable patients. The benefits to be derived from the use of the capsule will vary based on several variables.
What Makes The Medicine a Targeted Treatment Option?
Oral medication option is available for Niraparib 100mg capsule in ovarian cancer treatment and hence can be taken at home under the instructions provided by the oncologist. The mechanism of action is targeted, where the drug targets the PARP enzymes responsible for DNA repair. However, all people suffering from ovarian cancer do not qualify for treatment.
Conclusion
The medicine is a form of a targeted therapy that can be beneficial for eligible patients in retaining the efficacy of their treatment with platinum-based drugs and slowing down the development of ovarian cancer. The PARP inhibition effect of the therapy provides a new way of treating cancer by blocking the DNA repair process. However, this medication works extremely well because of its capacity to block PARP enzymes, thereby stopping cancer cells from repairing themselves and damaging their DNA, thus delaying the development of ovarian cancer.
FAQs
1. Does the capsule help in preventing recurrence of ovarian cancer?
It can delay cancer progression in suitable patients, but it does not provide any assurance against the occurrence of cancer.
2. What monitoring is required during the therapy?Usually, monitoring of blood counts and blood pressure is done by doctors for patients undergoing such targeted therapy.